13F HOLDINGS REPORT
DAFNA Capital Management LLC
Quarter ended Q1 2023 · Filed February 14, 2023 · Accession 0001389933-23-000002
Total Value
$355.1M
Positions
79
Other Managers
1
Confidential Omitted
No
Holdings (79)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SPDR S&P BIOTECH ETF | 78464A870 | 566,000 | $47.0M | 13.23% |
| 2 | STEREOTAXIS INC | STXS | 13,680,554 | $28.3M | 7.98% |
| 3 | ASCENDIS PHARMA A/S | ASND | 130,212 | $15.9M | 4.48% |
| 4 | KARUNA THERAPEUTICS INC | 48576A100 | 72,027 | $14.2M | 3.99% |
| 5 | ISHARES NASDAQ BIOTECH INDX | 464287556 | 102,500 | $13.5M | 3.79% |
| 6 | IVERIC BIO INC | 46583P102 | 605,975 | $13.0M | 3.65% |
| 7 | XENON PHARMACEUTICALS INC | XENE | 316,092 | $12.5M | 3.51% |
| 8 | BLUEPRINT MEDICINES CORP | 09627Y109 | 261,235 | $11.4M | 3.22% |
| 9 | REVOLUTION MEDICINES INC | RVMDW | 477,785 | $11.4M | 3.21% |
| 10 | SYNDAX PHARMACEUTICALS INC | SNDX | 447,073 | $11.4M | 3.20% |
| 11 | NEUROCRINE BIOSCIENCES INC | NBIX | 73,121 | $8.7M | 2.46% |
| 12 | IDEAYA BIOSCIENCES INC | IDYA | 468,358 | $8.5M | 2.40% |
| 13 | CYTOKINETICS INC | CYTK | 183,995 | $8.4M | 2.37% |
| 14 | DEXCOM INC | DXCM | 67,552 | $7.6M | 2.15% |
| 15 | SAGE THERAPEUTICS INC | 78667J108 | 180,306 | $6.9M | 1.94% |
| 16 | EDGEWISE THERAPEUTICS INC | EWTX | 766,843 | $6.9M | 1.93% |
| 17 | NURIX THERAPEUTICS INC | NRIX | 566,695 | $6.2M | 1.75% |
| 18 | ADICET BIO INC | ACET | 631,554 | $5.6M | 1.59% |
| 19 | FATE THERAPEUTICS INC | FATE | 550,940 | $5.6M | 1.57% |
| 20 | BIOHAVEN LTD | BHVN | 393,113 | $5.5M | 1.54% |
| 21 | MORPHIC HOLDING INC | 61775R105 | 195,467 | $5.2M | 1.47% |
| 22 | ALECTOR INC | ALEC | 532,438 | $4.9M | 1.38% |
| 23 | VIKING THERAPEUTICS INC | VKTX | 521,553 | $4.9M | 1.38% |
| 24 | APELLIS PHARMACEUTICALS INC | APLS | 83,446 | $4.3M | 1.22% |
| 25 | MERUS N V | N5749R100 | 269,893 | $4.2M | 1.18% |
| 26 | KALVISTA PHARMACEUTICALS INC | KALV | 616,032 | $4.2M | 1.17% |
| 27 | 89BIO INC | 282559103 | 324,173 | $4.1M | 1.16% |
| 28 | CARDIOVASCULAR SYSTEMS | 141619106 | 286,988 | $3.9M | 1.10% |
| 29 | DICE THERAPEUTICS INC | 23345J104 | 123,500 | $3.9M | 1.09% |
| 30 | F-STAR THERAPEUTICS INC | 30315R107 | 576,881 | $3.6M | 1.03% |
| 31 | BICYCLE THERAPEUTICS PLC | BCYC | 122,200 | $3.6M | 1.02% |
| 32 | MIRATI THERAPEUTICS INC | 60468T105 | 73,600 | $3.3M | 0.94% |
| 33 | AXOGEN INC | AXGN | 332,103 | $3.3M | 0.93% |
| 34 | ATRICURE INC | ATRC | 72,029 | $3.2M | 0.90% |
| 35 | COMPASS THERAPEUTICS INC | CMPX | 602,051 | $3.0M | 0.85% |
| 36 | ARCUS BIOSCIENCES INC | RCUS | 142,217 | $2.9M | 0.83% |
| 37 | BIOCRYST PHARMACEUTICALS INC | BCRX | 251,000 | $2.9M | 0.81% |
| 38 | MEDIWOUND LTD | MDWD | 204,082 | $2.8M | 0.78% |
| 39 | ACCURAY INC | ARAY | 1,222,358 | $2.6M | 0.72% |
| 40 | CENTURY THERAPEUTICS INC | IPSC | 475,367 | $2.4M | 0.69% |
| 41 | MERSANA THERAPEUTICS INC | 59045L106 | 413,463 | $2.4M | 0.68% |
| 42 | GALAPAGOS NV | GLPGF | 52,675 | $2.3M | 0.66% |
| 43 | AUTOLUS THERAPEUTICS PLC | AUTL | 1,176,150 | $2.2M | 0.63% |
| 44 | NEURONETICS INC | STIM | 313,717 | $2.2M | 0.61% |
| 45 | VIGIL NEUROSCIENCE INC | 92673K108 | 168,846 | $2.1M | 0.59% |
| 46 | LARIMAR THERAPEUTICS INC | LRMR | 473,136 | $2.0M | 0.55% |
| 47 | ITEOS THERAPEUTICS INC | 46565G104 | 98,560 | $1.9M | 0.54% |
| 48 | KURA ONCOLOGY INC | KURA | 144,784 | $1.8M | 0.51% |
| 49 | KEROS THERAPEUTICS INC | KROS | 33,000 | $1.6M | 0.45% |
| 50 | ORIC PHARMACEUTICALS INC | ORIC | 264,237 | $1.6M | 0.44% |
| 51 | CYMABAY THERAPEUTICS INC | 23257D103 | 171,059 | $1.1M | 0.30% |
| 52 | SYROS PHARMACEUTICALS INC | 87184Q206 | 265,878 | $954,502 | 0.27% |
| 53 | GENFIT S A | 372279109 | 197,940 | $868,759 | 0.24% |
| 54 | AFFIMED N V | N01045108 | 686,282 | $850,990 | 0.24% |
| 55 | MEREO BIOPHARMA GROUP PLC | MREO | 1,096,513 | $822,385 | 0.23% |
| 56 | PARDES BIOSCIENCES INC | 69945Q105 | 479,386 | $810,162 | 0.23% |
| 57 | REGULUS THERAPEUTICS INC | 75915K309 | 555,555 | $761,110 | 0.21% |
| 58 | KARYOPHARM THERAPEUTICS INC | KPTI | 192,678 | $655,105 | 0.18% |
| 59 | SURFACE ONCOLOGY INC | 86877M209 | 783,000 | $642,060 | 0.18% |
| 60 | CINCOR PHARMA INC | 17240Y109 | 48,000 | $589,920 | 0.17% |
| 61 | BRAINSWAY LTD | BRSYF | 220,000 | $543,400 | 0.15% |
| 62 | ADAPTIMMUNE THERAPEUTICS PLC | ADTI | 351,064 | $512,553 | 0.14% |
| 63 | MASIMO CORP | MASI | 3,000 | $443,850 | 0.13% |
| 64 | KINNATE BIOPHARMA INC | 49705R105 | 71,008 | $433,149 | 0.12% |
| 65 | THESEUS PHARMACEUTICALS INC | 88369M101 | 81,859 | $407,658 | 0.11% |
| 66 | IKENA ONCOLOGY INC | 45175G108 | 122,517 | $325,895 | 0.09% |
| 67 | MEDICENNA THERAPEUTICS CORP | MDNAF | 660,000 | $302,280 | 0.09% |
| 68 | INOGEN INC | INGN | 15,000 | $295,650 | 0.08% |
| 69 | BIOMEA FUSION INC | BMEA | 34,625 | $291,889 | 0.08% |
| 70 | MACROGENICS INC | MGNX | 39,879 | $267,588 | 0.08% |
| 71 | NEXTCURE INC | NXTC | 187,696 | $264,651 | 0.07% |
| 72 | SCYNEXIS INC | SCYX | 153,269 | $239,100 | 0.07% |
| 73 | SPERO THERAPEUTICS INC | SPRO | 125,000 | $216,250 | 0.06% |
| 74 | ACRIVON THERAPEUTICS INC | ACRV | 15,648 | $180,265 | 0.05% |
| 75 | BLACK DIAMOND THERAPEUTICS I | BDTX | 97,500 | $175,500 | 0.05% |
| 76 | LINEAGE CELL THERAPEUTICS IN | 53566P109 | 140,000 | $163,800 | 0.05% |
| 77 | COMPUGEN LTD | CGEN | 205,202 | $146,863 | 0.04% |
| 78 | REUNION NEUROSCIENCE INC | 76134G103 | 47,679 | $42,911 | 0.01% |
| 79 | PHASEBIO PHARMACEUTICALS INC | 717224109 | 321,856 | $9,688 | 0.00% |